Knight Therapeutics Inc.

TSX:GUD.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$11.56 +0.75%

+$0.07 today

Market cap
$1.14B
Beta
0.07
P/E (TTM)
164.6
EPS (TTM)
$0.06
52W Low $5.66High $9.59

Volume 0.04M

Average 0.10M

GUD.TO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Knight Therapeutics Inc.TSX: GUD.TO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 98.93M shares fell 1.2% year over year, in line with the -1.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.3% from the prior quarter. Over 3 fiscal years it compounded at -4.7% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -1.2% holds above the trailing-twelve-month pace of -1.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
98.93M-0.3% QoQ
Last fiscal yearDec 2025
99.57M-1.8% YoY
LTMMar 2026
99.35M-1.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.2%——
1 year-1.8%——
3-year CAGR-4.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
99.57M CAD
Year-over-year change
-1.8%
4-year CAGR
-5.4%

Weighted Avg Shares (Diluted) vs competitors

How GUD.TO compares with its peers on the latest reported figures

  • GUD.TO's LTM Mar 2026 weighted avg shares (diluted) of 99.35M shares is the 4th highest of the 8 companies compared; the peer median is 95.31M shares.
  • Its year-over-year change of -1.6% is the lowest of 8, against a peer median of +5.0%.
  • Over three fiscal years its annual growth of -4.7% compares with a peer median of +7.8%.
GUD.TO Competitors Peer median
Weighted Avg Shares (Diluted) for GUD.TO and competitors
Company Period LTM YoY 3-year CAGR
TSND.TOTerrAscend Corp.LTM Mar 2026305.61M +4.7%+7.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026134.1M +15.6%—
GUD.TOKnight Therapeutics Inc.LTM Mar 202699.35M -1.6%-4.7%
KSI.TOKneat.com, Inc.LTM Mar 202695.31M +5.0%+7.0%
VHI.TOVitalhub Corp.LTM Mar 202661.82M +18.3%+12.3%
ACB.TOAurora Cannabis Inc.LTM Mar 202656.7M +3.3%+20.7%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202626.09M +3.3%+0.5%
Peer median (excluding GUD.TO) 95.31M+5.0%+7.8%

Competitors are the stored peer set for GUD.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue243.48M293.56M328.2M371.3M450.09M
Cost of Revenue128.07M155.5M175.55M196.9M299.35M
Gross Profit115.41M138.06M152.65M174.41M150.74M
Gross Margin47.4%47.0%46.5%47.0%33.5%
Research & Development12.69M14.76M17.55M23.3M28.98M
Selling, General & Admin74.38M88.62M83.69M99.35M123.96M
Operating Expenses128.24M155.12M155.54M167.01M152.94M
Depreciation & Amortization47.92M62.62M50.4M53.11M56.57M
EBITDA42.59M25.26M40.9M64.38M54.37M
EBITDA Margin17.5%8.6%12.5%17.3%12.1%
Operating Income(5.32M)(2.4M)(2.89M)7.4M(2.2M)
Operating Margin-2.2%-0.8%-0.9%2.0%-0.5%
Interest Income7.38M10.63M12.58M10.41M6.21M
Interest Expense3.62M6.6M12.49M9.22M10.42M
Other Income / Expenses19.52M(2.92M)(19.1M)(5.35M)(4.5M)
Income Before Tax6.69M(43.96M)(21.99M)2.05M(6.7M)
Pre-Tax Margin2.7%-15.0%-6.7%0.6%-1.5%
Income Tax Expense(8.99M)(14.07M)(5.15M)(2.28M)(1.33M)
Net Income15.68M(29.89M)(16.84M)4.33M(5.37M)
Net Margin6.4%-10.2%-5.1%1.2%-1.2%
EPS (Basic)0.13(0.26)(0.16)0.04(0.05)
EPS (Diluted)0.13(0.26)(0.16)0.04(0.05)
Weighted Avg Shares124.48M114.89M107.47M101.04M99.57M
Weighted Avg Shares (Diluted)124.52M114.89M107.47M101.44M99.57M

Knight Therapeutics Inc.

TSX:GUD.TO

Intrinsic Alpha fair value

Locked

Current Price

$11.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.